We are live on ! Find out more
IBB icon

iShares Biotechnology ETF
IBB

902 hedge funds and large institutions have $5.97B invested in iShares Biotechnology ETF in 2022 Q4 according to their latest regulatory filings, with 140 funds opening new positions, 257 increasing their positions, 290 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

218% more first-time investments, than exits

New positions opened: 140 | Existing positions closed: 44

57% more funds holding in top 10

Funds holding in top 10: 14 → 22 (+8)

31% more capital invested

Capital invested by funds: $4.57B → $5.97B (+$1.41B)

9% more funds holding

Funds holding: 829 → 902 (+73)

3.64% more ownership

Funds ownership: 61.66% → 65.3% (+3.6%)

11% less repeat investments, than reductions

Existing positions increased: 257 | Existing positions reduced: 290

36% less call options, than puts

Call options by funds: $325M | Put options by funds: $511M

Holders
902
Holders Change
+73
Holders Change %
+8.81%
% of All Funds
14.5%
Holding in Top 10
22
Holding in Top 10 Change
+8
Holding in Top 10 Change %
+57.14%
% of All Funds
0.35%
New
140
Increased
257
Reduced
290
Closed
44
Calls
$325M
Puts
$511M
Net Calls
-$186M
Net Calls Change
+$278M

Top Buyers

Rank Fund Capital Flow
1
CANY
Caxton Associates (New York)
New York
+$149M
2
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
+$137M
3
E
Ergoteles
New York
+$85.8M
4
Goldman Sachs
Goldman Sachs
New York
+$72.3M
5
Bank of Nova Scotia
Bank of Nova Scotia
Ontario, Canada
+$51.7M

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$77.3M
2
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$58.8M
3
Barclays
Barclays
United Kingdom
-$50.3M
4
Bank of America
Bank of America
North Carolina
-$49.4M
5
MMEA
Main Management ETF Advisors
California
-$20.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
NFSG
776
Newbridge Financial Services Group
Florida
$45.8K – – –
BG
777
Bollard Group
Massachusetts
$44K +$129 +1 +0.3%
DSC
778
Duncker Streett & Co
Missouri
$43.9K -$27.1K -210 -39%
OCM
779
Osterweis Capital Management
California
$43.7K – – –
MMG
780
Monetary Management Group
Missouri
$42.7K – – –
FP
781
Financial Perspectives
Minnesota
$41.8K – – –
IFAM
782
Institutional & Family Asset Management
Colorado
$41.6K – – –
Lazard Asset Management
783
Lazard Asset Management
New York
$41K – – –
CFB
784
Cullen/Frost Bankers
Texas
$39.4K -$78.3K -606 -67%
RLIM
785
Red Lighthouse Investment Management
New York
$39.4K +$38.8K +300 New
LAM
786
Lakewood Asset Management
Illinois
$39K +$38.8K +300 New
VFA
787
Values First Advisors
Tennessee
$38.9K +$38.3K +296 New
LWCFA
788
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
$38.3K – – –
IF
789
Integrity Financial
Wyoming
$37.9K – – –
PFM
790
Phillips Financial Management
Indiana
$36.1K – – –
TCA
791
Trifecta Capital Advisors
Illinois
$36.1K +$35.5K +275 New
CWP
792
Concord Wealth Partners
Virginia
$35.6K +$35K +271 New
FFA
793
Farther Finance Advisors
California
$35.2K +$34.6K +268 New
FAM
794
Family Asset Management
South Carolina
$34.9K +$34.4K +266 New
PWMG
795
Prestige Wealth Management Group
New Jersey
$33.5K -$11.2K -87 -25%
IBOK
796
Independence Bank of Kentucky
Kentucky
$32K – – –
AAMA
797
Advanced Asset Management Advisors
Ohio
$31.5K – – –
SFC
798
SYM Financial Corp
Indiana
$31.1K +$14.2K +110 +87%
HIIFS
799
Harel Insurance Investments & Financial Services
Israel
$31K – – –
AWM
800
Accurate Wealth Management
Florida
$30.6K +$29.7K +230 New
30 31
32
33 34

IBB Hedge Fund Activity: Q4 2022 in Review

902 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in iShares Biotechnology ETF (IBB) for Q4 2022, worth a combined $5.97B — up 31% from $4.57B a quarter earlier.

Buyers outnumbered sellers: 140 funds opened new IBB positions and 44 closed out — a net gain of 96 holders — while 257 added to existing stakes and 290 trimmed.

The largest buyer was Caxton Associates (New York), opening a new position worth an estimated $149M. The largest seller was Morgan Stanley, cutting an estimated $77.3M.

  • 902 institutional investors held iShares Biotechnology ETF (IBB) as of Q4 2022, up from 829 in Q3 2022.
  • Funds reported $5.97B of iShares Biotechnology ETF stock for Q4 2022, up 31% quarter-over-quarter.
  • 140 funds opened new iShares Biotechnology ETF positions in Q4 2022 and 44 closed out, a net change of +96 holders.
  • The largest iShares Biotechnology ETF buyer in Q4 2022 was Caxton Associates (New York), an estimated $149M added.
  • The largest iShares Biotechnology ETF seller in Q4 2022 was Morgan Stanley, an estimated $77.3M sold.

Based on aggregated 13F filings for Q4 2022.